Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.32 |
| ▸ | FEN1 | P39748 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | NQO2 | P16083 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL943394 | 0.84 | APOBEC3G (0.48) | LMNAGAAALOX15TDP1OPRL1 | |
| SCHEMBL513976 | 0.82 | SLC6A2 (0.43) | LMNAGAASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL3483641 | 0.78 | PSIP1 (0.44) | LMNA | |
| SCHEMBL775854 | 0.77 | GABRA1 (0.41) | LMNAAPOBEC3GSLC6A2SLC6A4 | |
| SCHEMBL9256894 | 0.73 | GABRA1 (0.41) | LMNAGAAALOX15TDP1CA1 | |
| SCHEMBL2376651 | 0.71 | ALDH1A1 (0.49) | LMNAGAACA2 | |
| SCHEMBL2634762 | 0.71 | GAA (0.43) | LMNAGAAALOX15TDP1OPRL1 | |
| SCHEMBL30659891 | 0.71 | GAA (0.43) | LMNAGAAALOX15TDP1OPRL1 | |
| SCHEMBL23004816 | 0.69 | PNMT (0.41) | LMNAGAAALOX15TDP1CA1 | |
| SCHEMBL647765 | 0.69 | ALDH1A1 (0.39) | LMNAGAAALOX15TDP1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7851646-B2 | formed by reacting aryl sulfur compound with halogen and fluoro salt to form arylsulfur halotetrafluoride which is reacted with fluoride source to form target arylsulfur pentafluoride; for production of fungicides, herbicides, and insecticides | IM&T RESEARCH, INC. (US) | 2010-12-14 | — | — | US | disclosed |
| US-20100076215-A9 | Process for Producing Arylsulfur Pentafluorides | IM&T RESEARCH, INC. (US) | 2010-03-25 | — | — | US | disclosed |
| US-20090287024-A1 | Process for Producing Arylsulfur Pentafluorides | IM&T RESEARCH, INC. (US) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090287024-A1 | Process for Producing Arylsulfur Pentafluorides | PFAS, MPST, ARSA | LMNA 4733/4885GAA 1978/4885ALOX15 3399/4885 |
| US-20100076215-A9 | Process for Producing Arylsulfur Pentafluorides | PFAS, MPST, ARSA | LMNA 4733/4885GAA 1978/4885ALOX15 3399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.